Department of General Surgery, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Department of Gastrointestinal Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Surg Endosc. 2019 Jun;33(6):1802-1810. doi: 10.1007/s00464-018-6455-y. Epub 2019 Jan 30.
The recurrence of stones after endoscopic minimally invasive cholecystolithotomy (EMIC) remains a hazardous problem in patients with cholelithasis. We sought to evaluate the risk factors for recurrence after cholecystolithotomy and to provide a theoretical basis for the indication for cholecystolithotomy.
We searched the Cochrane Library, PubMed, EMBASE, WanFang Data, CNKI and VIP Data to identify controlled trials related to cholelithasis that were published between 2007 and 2016. The odds ratios (ORs) were calculated with 95% confidence intervals (CIs). Stata12.0 was used to test the heterogeneity and publication bias.
Eight studies involving 1663 participants were selected. No significant differences were observed in hazardous factors including advanced age, gender and diabetes mellitus compared with the control groups. However, family history of cholelithasis, multiple calculi, gallbladder wall thickening (GBWT) over 3 mm, a preference for greasy food, dysfunction of the gallbladder and not taking oral ursodeoxycholic acid post-EMIC yielded pooled ORs (95% CI) of 3.28 (2.30, 4.66), 4.24 (2.76, 6.50), 18.4 (7.23, 46.83), 1.90 (1.20, 3.01), 26.16 (10.15, 62.34) and 2.90 (1.36, 6.15), respectively.
A family history of cholelithasis, multiple calculi, a GBWT ≥ 3 mm, a preference for greasy food, dysfunction of the gallbladder and not taking oral ursodeoxycholic acid post-EMIC are hazardous factors for stones and sludge after cholecystolithotomy.
内镜微创保胆取石术后(EMIC)结石复发仍然是胆石病患者的一个危险问题。我们试图评估保胆取石术后结石复发的危险因素,并为保胆取石的适应证提供理论依据。
我们检索了 Cochrane 图书馆、PubMed、EMBASE、万方数据、中国知网和维普数据,以确定 2007 年至 2016 年期间发表的与胆石症相关的对照试验。用 95%置信区间(CI)计算比值比(OR)。Stata12.0 用于检验异质性和发表偏倚。
纳入了 8 项研究,共 1663 名参与者。与对照组相比,危险因素如年龄较大、性别和糖尿病在危险程度上没有显著差异。然而,胆石症家族史、多发结石、胆囊壁增厚(GBWT)超过 3mm、偏好油腻食物、胆囊功能障碍和 EMIC 后不服用口服熊去氧胆酸的患者,其合并 OR(95%CI)分别为 3.28(2.30,4.66)、4.24(2.76,6.50)、18.4(7.23,46.83)、1.90(1.20,3.01)、26.16(10.15,62.34)和 2.90(1.36,6.15)。
胆石症家族史、多发结石、GBWT≥3mm、偏好油腻食物、胆囊功能障碍和 EMIC 后不服用口服熊去氧胆酸是保胆取石术后结石和泥沙样结石的危险因素。